

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.39955711 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.39955711 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.85252178 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.85252178 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.38427467 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.56058137 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.56058137 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.56058137 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.56021366 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.42974776 |
| 11 | behavioral response to nicotine (GO:0035095) | 5.34490940 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.28908857 |
| 13 | auditory behavior (GO:0031223) | 5.25918560 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.24623827 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.18153450 |
| 16 | urea cycle (GO:0000050) | 4.99362103 |
| 17 | urea metabolic process (GO:0019627) | 4.99362103 |
| 18 | cell migration in hindbrain (GO:0021535) | 4.98827014 |
| 19 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.83642054 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.83450916 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.81298890 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.74546619 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.73140275 |
| 24 | cysteine metabolic process (GO:0006534) | 4.72844935 |
| 25 | bile acid metabolic process (GO:0008206) | 4.71193268 |
| 26 | cellular ketone body metabolic process (GO:0046950) | 4.70210200 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.63660050 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.61817756 |
| 29 | neurofilament cytoskeleton organization (GO:0060052) | 4.60399558 |
| 30 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.55321994 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.54102355 |
| 32 | peristalsis (GO:0030432) | 4.51654851 |
| 33 | protein carboxylation (GO:0018214) | 4.46648201 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.46648201 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.44963773 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.40066030 |
| 37 | coenzyme catabolic process (GO:0009109) | 4.39850676 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.39533090 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.33150566 |
| 40 | fatty acid elongation (GO:0030497) | 4.30542658 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 4.24644438 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.20546054 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.18593055 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.18593055 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.18593055 |
| 46 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.18152600 |
| 47 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.18152600 |
| 48 | presynaptic membrane assembly (GO:0097105) | 4.17517896 |
| 49 | cellular glucuronidation (GO:0052695) | 4.16870242 |
| 50 | neuron recognition (GO:0008038) | 4.12594807 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.12487797 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.12487797 |
| 53 | cholesterol efflux (GO:0033344) | 4.11261080 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 4.10710562 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.09431886 |
| 56 | regulation of complement activation (GO:0030449) | 4.08546075 |
| 57 | ketone body metabolic process (GO:1902224) | 4.07711336 |
| 58 | protein localization to synapse (GO:0035418) | 4.06740018 |
| 59 | amine catabolic process (GO:0009310) | 4.06221120 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.06221120 |
| 61 | phospholipid efflux (GO:0033700) | 4.02849374 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 4.01933212 |
| 63 | homocysteine metabolic process (GO:0050667) | 4.01297057 |
| 64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99604748 |
| 65 | postsynaptic membrane organization (GO:0001941) | 3.98963581 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.97781595 |
| 67 | mechanosensory behavior (GO:0007638) | 3.97204193 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.97034212 |
| 69 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.96693765 |
| 70 | protein localization to cilium (GO:0061512) | 3.96492154 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92631681 |
| 72 | uronic acid metabolic process (GO:0006063) | 3.92247631 |
| 73 | glucuronate metabolic process (GO:0019585) | 3.92247631 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 3.91962776 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.91339872 |
| 76 | negative regulation of sterol transport (GO:0032372) | 3.91023390 |
| 77 | negative regulation of cholesterol transport (GO:0032375) | 3.91023390 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 3.90262469 |
| 79 | axonal fasciculation (GO:0007413) | 3.88879763 |
| 80 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.85132475 |
| 81 | drug catabolic process (GO:0042737) | 3.82402454 |
| 82 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.80769477 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.80605394 |
| 84 | synapse assembly (GO:0007416) | 3.79712637 |
| 85 | fibrinolysis (GO:0042730) | 3.79080777 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78314665 |
| 87 | dendrite morphogenesis (GO:0048813) | 3.77264182 |
| 88 | opsonization (GO:0008228) | 3.76277306 |
| 89 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75627746 |
| 90 | response to auditory stimulus (GO:0010996) | 3.74841775 |
| 91 | cholesterol biosynthetic process (GO:0006695) | 3.73780345 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.71700649 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 3.71340605 |
| 94 | synaptic transmission, cholinergic (GO:0007271) | 3.71030731 |
| 95 | dendritic spine morphogenesis (GO:0060997) | 3.69934532 |
| 96 | glutamate metabolic process (GO:0006536) | 3.69092671 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.68639051 |
| 98 | arginine metabolic process (GO:0006525) | 3.68189060 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.67710761 |
| 100 | very long-chain fatty acid metabolic process (GO:0000038) | 3.67266292 |
| 101 | neuron cell-cell adhesion (GO:0007158) | 3.65867780 |
| 102 | cofactor catabolic process (GO:0051187) | 3.65290491 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.61220802 |
| 104 | amino-acid betaine metabolic process (GO:0006577) | 3.59992130 |
| 105 | negative regulation of lipase activity (GO:0060192) | 3.58949938 |
| 106 | benzene-containing compound metabolic process (GO:0042537) | 3.58070399 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 3.57757493 |
| 108 | intestinal cholesterol absorption (GO:0030299) | 3.56755742 |
| 109 | cellular amino acid catabolic process (GO:0009063) | 3.56663746 |
| 110 | blood coagulation, intrinsic pathway (GO:0007597) | 3.55951725 |
| 111 | positive regulation of growth hormone secretion (GO:0060124) | 3.55769198 |
| 112 | behavioral response to ethanol (GO:0048149) | 3.55244949 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51664545 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51664545 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.45919598 |
| 116 | retinal ganglion cell axon guidance (GO:0031290) | 3.43283187 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.42542966 |
| 118 | nucleobase catabolic process (GO:0046113) | 3.40675163 |
| 119 | cellular modified amino acid catabolic process (GO:0042219) | 3.39725800 |
| 120 | sterol homeostasis (GO:0055092) | 3.39512178 |
| 121 | response to nitrosative stress (GO:0051409) | 3.37340027 |
| 122 | mitochondrion transport along microtubule (GO:0047497) | 3.36254859 |
| 123 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.36254859 |
| 124 | lysine catabolic process (GO:0006554) | 3.32379795 |
| 125 | lysine metabolic process (GO:0006553) | 3.32379795 |
| 126 | protein-lipid complex assembly (GO:0065005) | 3.31408055 |
| 127 | regulation of dopamine secretion (GO:0014059) | 3.31159111 |
| 128 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.31020649 |
| 129 | striatum development (GO:0021756) | 3.30348496 |
| 130 | spinal cord development (GO:0021510) | 3.28141737 |
| 131 | protein activation cascade (GO:0072376) | 3.28059974 |
| 132 | short-chain fatty acid metabolic process (GO:0046459) | 3.27528239 |
| 133 | exogenous drug catabolic process (GO:0042738) | 3.26624042 |
| 134 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.25756916 |
| 135 | establishment of mitochondrion localization (GO:0051654) | 3.25634160 |
| 136 | ethanol oxidation (GO:0006069) | 3.25539128 |
| 137 | sterol biosynthetic process (GO:0016126) | 3.22813879 |
| 138 | drug metabolic process (GO:0017144) | 3.22478243 |
| 139 | serine family amino acid metabolic process (GO:0009069) | 3.22035750 |
| 140 | response to histamine (GO:0034776) | 3.19803540 |
| 141 | plasma lipoprotein particle organization (GO:0071827) | 3.19612146 |
| 142 | complement activation, classical pathway (GO:0006958) | 3.19218598 |
| 143 | negative regulation of catecholamine secretion (GO:0033604) | 3.18379919 |
| 144 | axon extension (GO:0048675) | 3.18302513 |
| 145 | neuronal ion channel clustering (GO:0045161) | 3.17475765 |
| 146 | regulation of respiratory system process (GO:0044065) | 3.16907283 |
| 147 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.10282514 |
| 148 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07857502 |
| 149 | hindbrain development (GO:0030902) | 3.07414609 |
| 150 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.06360842 |
| 151 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.06360842 |
| 152 | regulation of growth hormone secretion (GO:0060123) | 3.04533937 |
| 153 | transmission of nerve impulse (GO:0019226) | 3.03680841 |
| 154 | short-term memory (GO:0007614) | 3.01161058 |
| 155 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.92874509 |
| 156 | behavioral response to cocaine (GO:0048148) | 2.91469003 |
| 157 | cell differentiation in hindbrain (GO:0021533) | 2.86444360 |
| 158 | synapse organization (GO:0050808) | 2.84145247 |
| 159 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.82663770 |
| 160 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.82663770 |
| 161 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.82663770 |
| 162 | adult walking behavior (GO:0007628) | 2.81671272 |
| 163 | neuron migration (GO:0001764) | 2.80373229 |
| 164 | central nervous system neuron axonogenesis (GO:0021955) | 2.78631343 |
| 165 | response to inactivity (GO:0014854) | 2.77959283 |
| 166 | positive regulation of synapse assembly (GO:0051965) | 2.74628579 |
| 167 | regulation of respiratory gaseous exchange (GO:0043576) | 2.74075072 |
| 168 | layer formation in cerebral cortex (GO:0021819) | 2.73281822 |
| 169 | dopamine receptor signaling pathway (GO:0007212) | 2.72550727 |
| 170 | vocalization behavior (GO:0071625) | 2.72353438 |
| 171 | ganglion development (GO:0061548) | 2.69833053 |
| 172 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.65128284 |
| 173 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.65064720 |
| 174 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.64418260 |
| 175 | neuron maturation (GO:0042551) | 2.62781093 |
| 176 | body morphogenesis (GO:0010171) | 2.60607415 |
| 177 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.60266014 |
| 178 | sympathetic nervous system development (GO:0048485) | 2.57880487 |
| 179 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.56307209 |
| 180 | motor neuron axon guidance (GO:0008045) | 2.55072937 |
| 181 | skeletal muscle organ development (GO:0060538) | 2.54614417 |
| 182 | phasic smooth muscle contraction (GO:0014821) | 2.54148623 |
| 183 | cerebellar granule cell differentiation (GO:0021707) | 2.52474266 |
| 184 | spinal cord association neuron differentiation (GO:0021527) | 2.52291677 |
| 185 | synaptic transmission, glutamatergic (GO:0035249) | 2.52196388 |
| 186 | response to nicotine (GO:0035094) | 2.51778514 |
| 187 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.49376069 |
| 188 | prepulse inhibition (GO:0060134) | 2.49199416 |
| 189 | cranial nerve morphogenesis (GO:0021602) | 2.48570320 |
| 190 | membrane depolarization during action potential (GO:0086010) | 2.48307074 |
| 191 | synaptic transmission, dopaminergic (GO:0001963) | 2.48287128 |
| 192 | neuron projection extension (GO:1990138) | 2.47593005 |
| 193 | regulation of axon guidance (GO:1902667) | 2.47379057 |
| 194 | dendrite development (GO:0016358) | 2.47162158 |
| 195 | neuronal action potential (GO:0019228) | 2.46596909 |
| 196 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.46221770 |
| 197 | * endocrine pancreas development (GO:0031018) | 2.45943438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.71367971 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41816988 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.90914951 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.37266577 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.37109820 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.53017033 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.11475352 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.88216957 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53599604 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.47941279 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.35971809 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20043672 |
| 13 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02300556 |
| 14 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00673769 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.95965544 |
| 16 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.83970518 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81799637 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.78653003 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.72208856 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71172571 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.59094796 |
| 22 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.57522684 |
| 23 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.54509799 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52636908 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49455148 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44933106 |
| 27 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43718494 |
| 28 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.43621771 |
| 29 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.42790322 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38772214 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37085577 |
| 32 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.35101853 |
| 33 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34118434 |
| 34 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.31471051 |
| 35 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30379901 |
| 36 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30188551 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29684389 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28041813 |
| 39 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27565650 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26737079 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26726774 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26233292 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25706928 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24249138 |
| 45 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21941454 |
| 46 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21864725 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21372467 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21094274 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20343401 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20309142 |
| 51 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19924421 |
| 52 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19871003 |
| 53 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17523271 |
| 54 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17523271 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17365599 |
| 56 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17214373 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17102319 |
| 58 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16046773 |
| 59 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16024093 |
| 60 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15982973 |
| 61 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.15937894 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15765692 |
| 63 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15756943 |
| 64 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.15666577 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14565717 |
| 66 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14478465 |
| 67 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13165625 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11638742 |
| 69 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11366208 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11034391 |
| 71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09377152 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08974252 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08129117 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08129117 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07728474 |
| 76 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07642167 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07396703 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06985426 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06957156 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06174689 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.05035355 |
| 82 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03876319 |
| 83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03873424 |
| 84 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03172543 |
| 85 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02799154 |
| 86 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01773168 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01440145 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01140034 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00755430 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00367300 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99553317 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98860662 |
| 93 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97977772 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97960941 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97497326 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97438273 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97292151 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97219963 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96619630 |
| 100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95998770 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95512431 |
| 102 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95220552 |
| 103 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95189443 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95005739 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94682309 |
| 106 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93689128 |
| 107 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92511442 |
| 108 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91943680 |
| 109 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91564465 |
| 110 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90806529 |
| 111 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90711829 |
| 112 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90558958 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90256587 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89547493 |
| 115 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89249548 |
| 116 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.89092639 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88948244 |
| 118 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88372118 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87817528 |
| 120 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87706180 |
| 121 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87590003 |
| 122 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.87590003 |
| 123 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.87429562 |
| 124 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.87244325 |
| 125 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87077351 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87049123 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86905697 |
| 128 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86487166 |
| 129 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85887301 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85331870 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85034012 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84788258 |
| 133 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84550901 |
| 134 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84357644 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.82493439 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81735256 |
| 137 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81353248 |
| 138 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81353248 |
| 139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.80581816 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80547058 |
| 141 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78637305 |
| 142 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.78382544 |
| 143 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78377578 |
| 144 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78156136 |
| 145 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.77759929 |
| 146 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.77668186 |
| 147 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.77565311 |
| 148 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77393799 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76829558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.56338464 |
| 2 | MP0005360_urolithiasis | 6.91688797 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.00832719 |
| 4 | MP0005365_abnormal_bile_salt | 5.32054979 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.85134131 |
| 6 | MP0003252_abnormal_bile_duct | 3.67341886 |
| 7 | MP0001188_hyperpigmentation | 3.45854256 |
| 8 | MP0005083_abnormal_biliary_tract | 3.36482327 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.28860326 |
| 10 | MP0003195_calcinosis | 2.94848635 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.94701613 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.71568220 |
| 13 | MP0003787_abnormal_imprinting | 2.60425218 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.56277911 |
| 15 | MP0003122_maternal_imprinting | 2.43023850 |
| 16 | MP0005332_abnormal_amino_acid | 2.30264873 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.23918738 |
| 18 | MP0005451_abnormal_body_composition | 2.18334371 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.17931727 |
| 20 | MP0005187_abnormal_penis_morphology | 2.15227551 |
| 21 | MP0009840_abnormal_foam_cell | 2.13668709 |
| 22 | MP0003868_abnormal_feces_composition | 2.06874215 |
| 23 | MP0003123_paternal_imprinting | 2.05528801 |
| 24 | MP0003121_genomic_imprinting | 2.02645352 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.01731945 |
| 26 | MP0000955_abnormal_spinal_cord | 1.96859852 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 1.84803237 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.84273697 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 1.82954816 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.80415592 |
| 31 | MP0004859_abnormal_synaptic_plasticity | 1.75080258 |
| 32 | MP0003011_delayed_dark_adaptation | 1.74566087 |
| 33 | MP0002184_abnormal_innervation | 1.73282145 |
| 34 | MP0000631_abnormal_neuroendocrine_gland | 1.70576859 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.69333813 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.66255742 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.61409966 |
| 38 | MP0005499_abnormal_olfactory_system | 1.61333144 |
| 39 | MP0005394_taste/olfaction_phenotype | 1.61333144 |
| 40 | MP0000609_abnormal_liver_physiology | 1.59397065 |
| 41 | MP0004133_heterotaxia | 1.57880756 |
| 42 | MP0009697_abnormal_copulation | 1.53879798 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.52430442 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.50776646 |
| 45 | MP0004924_abnormal_behavior | 1.50776646 |
| 46 | MP0009046_muscle_twitch | 1.48578867 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.44932063 |
| 48 | MP0003880_abnormal_central_pattern | 1.42636000 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.41950361 |
| 50 | MP0000566_synostosis | 1.37070946 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.36163358 |
| 52 | MP0001970_abnormal_pain_threshold | 1.34985202 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.34957244 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.33883239 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.32861688 |
| 56 | MP0008789_abnormal_olfactory_epithelium | 1.32106126 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.30895107 |
| 58 | MP0003690_abnormal_glial_cell | 1.29618584 |
| 59 | MP0002752_abnormal_somatic_nervous | 1.29133573 |
| 60 | MP0002638_abnormal_pupillary_reflex | 1.27635587 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.27342574 |
| 62 | MP0004270_analgesia | 1.25262930 |
| 63 | MP0000920_abnormal_myelination | 1.25121620 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24323060 |
| 65 | MP0003861_abnormal_nervous_system | 1.22412307 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.21229378 |
| 67 | MP0003329_amyloid_beta_deposits | 1.19661414 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.18786462 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.18362328 |
| 70 | MP0002822_catalepsy | 1.16968896 |
| 71 | MP0001764_abnormal_homeostasis | 1.14744327 |
| 72 | MP0000604_amyloidosis | 1.14108978 |
| 73 | MP0002152_abnormal_brain_morphology | 1.12851973 |
| 74 | MP0003119_abnormal_digestive_system | 1.11909340 |
| 75 | MP0003283_abnormal_digestive_organ | 1.11877514 |
| 76 | MP0002751_abnormal_autonomic_nervous | 1.08065785 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.07261475 |
| 78 | MP0005408_hypopigmentation | 1.05944446 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.04409806 |
| 80 | MP0000462_abnormal_digestive_system | 1.03853834 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.02519031 |
| 82 | MP0000534_abnormal_ureter_morphology | 0.98153371 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.97571214 |
| 84 | MP0001919_abnormal_reproductive_system | 0.87733074 |
| 85 | MP0002697_abnormal_eye_size | 0.86854569 |
| 86 | MP0009764_decreased_sensitivity_to | 0.85624750 |
| 87 | MP0003942_abnormal_urinary_system | 0.84653222 |
| 88 | MP0004381_abnormal_hair_follicle | 0.84366012 |
| 89 | MP0001486_abnormal_startle_reflex | 0.83486322 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.81951587 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.81687872 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.81665129 |
| 93 | MP0001286_abnormal_eye_development | 0.81159325 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.81152127 |
| 95 | MP0002163_abnormal_gland_morphology | 0.80575527 |
| 96 | MP0001529_abnormal_vocalization | 0.80442007 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.78817892 |
| 98 | MP0009053_abnormal_anal_canal | 0.78307589 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.78013663 |
| 100 | * MP0002928_abnormal_bile_duct | 0.77559371 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.76789929 |
| 102 | MP0008995_early_reproductive_senescence | 0.76649073 |
| 103 | MP0002081_perinatal_lethality | 0.76215543 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.75835577 |
| 105 | MP0005647_abnormal_sex_gland | 0.74707333 |
| 106 | MP0000778_abnormal_nervous_system | 0.73508938 |
| 107 | MP0004742_abnormal_vestibular_system | 0.72779703 |
| 108 | MP0001944_abnormal_pancreas_morphology | 0.72204231 |
| 109 | MP0003385_abnormal_body_wall | 0.71191413 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.71016598 |
| 111 | MP0001661_extended_life_span | 0.69727840 |
| 112 | MP0002233_abnormal_nose_morphology | 0.69138763 |
| 113 | MP0003632_abnormal_nervous_system | 0.69053768 |
| 114 | MP0005389_reproductive_system_phenotype | 0.68954432 |
| 115 | MP0004142_abnormal_muscle_tone | 0.68889447 |
| 116 | MP0002102_abnormal_ear_morphology | 0.68719872 |
| 117 | MP0005409_darkened_coat_color | 0.67745953 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.67441717 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.67044400 |
| 120 | MP0009763_increased_sensitivity_to | 0.65700256 |
| 121 | * MP0000598_abnormal_liver_morphology | 0.65023895 |
| 122 | MP0002229_neurodegeneration | 0.64563455 |
| 123 | MP0005535_abnormal_body_temperature | 0.62214539 |
| 124 | MP0002078_abnormal_glucose_homeostasis | 0.61792183 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.61034623 |
| 126 | MP0002272_abnormal_nervous_system | 0.61017438 |
| 127 | MP0004883_abnormal_blood_vessel | 0.59906799 |
| 128 | MP0008874_decreased_physiological_sensi | 0.58960166 |
| 129 | MP0003718_maternal_effect | 0.57773471 |
| 130 | MP0005334_abnormal_fat_pad | 0.56836351 |
| 131 | MP0004147_increased_porphyrin_level | 0.56780564 |
| 132 | MP0002735_abnormal_chemical_nociception | 0.54163347 |
| 133 | MP0003186_abnormal_redox_activity | 0.53485189 |
| 134 | MP0009745_abnormal_behavioral_response | 0.52887472 |
| 135 | MP0000579_abnormal_nail_morphology | 0.51892270 |
| 136 | MP0001905_abnormal_dopamine_level | 0.51687043 |
| 137 | MP0005448_abnormal_energy_balance | 0.51189617 |
| 138 | MP0008469_abnormal_protein_level | 0.50314237 |
| 139 | MP0002734_abnormal_mechanical_nocicepti | 0.49401152 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.49238133 |
| 141 | MP0001968_abnormal_touch/_nociception | 0.48992738 |
| 142 | MP0008872_abnormal_physiological_respon | 0.48884584 |
| 143 | MP0001664_abnormal_digestion | 0.47991076 |
| 144 | MP0006036_abnormal_mitochondrial_physio | 0.47775694 |
| 145 | MP0000538_abnormal_urinary_bladder | 0.47069340 |
| 146 | MP0005395_other_phenotype | 0.46143087 |
| 147 | MP0001324_abnormal_eye_pigmentation | 0.44923437 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.44104430 |
| 149 | MP0000427_abnormal_hair_cycle | 0.43602426 |
| 150 | MP0002064_seizures | 0.43259917 |
| 151 | MP0005379_endocrine/exocrine_gland_phen | 0.43165911 |
| 152 | MP0004885_abnormal_endolymph | 0.42751614 |
| 153 | MP0002572_abnormal_emotion/affect_behav | 0.42464753 |
| 154 | MP0002971_abnormal_brown_adipose | 0.42313324 |
| 155 | MP0002254_reproductive_system_inflammat | 0.42123361 |
| 156 | MP0001984_abnormal_olfaction | 0.41882410 |
| 157 | MP0002069_abnormal_eating/drinking_beha | 0.39608145 |
| 158 | MP0005195_abnormal_posterior_eye | 0.39496465 |
| 159 | MP0001440_abnormal_grooming_behavior | 0.39455368 |
| 160 | MP0003938_abnormal_ear_development | 0.38772672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.26026483 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.82507337 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.79909430 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.41726476 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.19893590 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.89010149 |
| 7 | Xanthomatosis (HP:0000991) | 5.48062111 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.05525431 |
| 9 | Complement deficiency (HP:0004431) | 4.64842334 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 4.57630919 |
| 11 | Epidermoid cyst (HP:0200040) | 4.36698220 |
| 12 | Joint hemorrhage (HP:0005261) | 4.35179359 |
| 13 | Fat malabsorption (HP:0002630) | 4.19062809 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 4.13781864 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.07502530 |
| 16 | Limb dystonia (HP:0002451) | 3.98195870 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.87508986 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.79277870 |
| 19 | Myokymia (HP:0002411) | 3.75984099 |
| 20 | Hyperglycinemia (HP:0002154) | 3.72508008 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.71368864 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.67464633 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.67311625 |
| 24 | Hyperammonemia (HP:0001987) | 3.55857529 |
| 25 | Abnormal pancreas size (HP:0012094) | 3.55780931 |
| 26 | Genetic anticipation (HP:0003743) | 3.47083554 |
| 27 | Drooling (HP:0002307) | 3.46085189 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43621522 |
| 29 | Ketosis (HP:0001946) | 3.40716939 |
| 30 | Exotropia (HP:0000577) | 3.40420463 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.40051953 |
| 32 | Osteomalacia (HP:0002749) | 3.32574692 |
| 33 | Broad-based gait (HP:0002136) | 3.28404248 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.27194788 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.27194788 |
| 36 | Agitation (HP:0000713) | 3.20202690 |
| 37 | Abnormality of complement system (HP:0005339) | 3.18686991 |
| 38 | Shawl scrotum (HP:0000049) | 3.15579447 |
| 39 | Excessive salivation (HP:0003781) | 3.13121099 |
| 40 | Hyperglycinuria (HP:0003108) | 3.10222590 |
| 41 | Focal seizures (HP:0007359) | 3.06561804 |
| 42 | Lissencephaly (HP:0001339) | 3.04489311 |
| 43 | Acanthocytosis (HP:0001927) | 3.03988721 |
| 44 | Steatorrhea (HP:0002570) | 3.02007526 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 3.01563606 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.99779198 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.90515207 |
| 48 | Torticollis (HP:0000473) | 2.89233930 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86707441 |
| 50 | Pachygyria (HP:0001302) | 2.82824627 |
| 51 | Parakeratosis (HP:0001036) | 2.81001458 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.76571532 |
| 53 | Cerebral edema (HP:0002181) | 2.75874101 |
| 54 | High anterior hairline (HP:0009890) | 2.75270516 |
| 55 | Cortical dysplasia (HP:0002539) | 2.73584908 |
| 56 | Spontaneous abortion (HP:0005268) | 2.69868044 |
| 57 | Hypophosphatemic rickets (HP:0004912) | 2.67468419 |
| 58 | Epileptic encephalopathy (HP:0200134) | 2.63848944 |
| 59 | Sensory axonal neuropathy (HP:0003390) | 2.61290252 |
| 60 | Hypoplasia of the brainstem (HP:0002365) | 2.56219730 |
| 61 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.56219730 |
| 62 | Amblyopia (HP:0000646) | 2.56145545 |
| 63 | Febrile seizures (HP:0002373) | 2.55730363 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.53246316 |
| 65 | Vascular calcification (HP:0004934) | 2.52112970 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50724185 |
| 67 | Hepatoblastoma (HP:0002884) | 2.50134685 |
| 68 | Skin nodule (HP:0200036) | 2.49711148 |
| 69 | Lethargy (HP:0001254) | 2.48150738 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.47670587 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.47592391 |
| 72 | Gait imbalance (HP:0002141) | 2.46879247 |
| 73 | Metabolic acidosis (HP:0001942) | 2.46171622 |
| 74 | Protruding tongue (HP:0010808) | 2.42097878 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.39640394 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.36948018 |
| 77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35331070 |
| 78 | Volvulus (HP:0002580) | 2.32539470 |
| 79 | Rickets (HP:0002748) | 2.31781909 |
| 80 | Oligodactyly (hands) (HP:0001180) | 2.29770404 |
| 81 | Fair hair (HP:0002286) | 2.27173462 |
| 82 | Spastic paraparesis (HP:0002313) | 2.26805094 |
| 83 | Glomerulonephritis (HP:0000099) | 2.24135219 |
| 84 | Macroorchidism (HP:0000053) | 2.23175603 |
| 85 | Ketoacidosis (HP:0001993) | 2.22481989 |
| 86 | Chronic hepatic failure (HP:0100626) | 2.21782083 |
| 87 | Amyloidosis (HP:0011034) | 2.20467809 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.20371565 |
| 89 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.19855766 |
| 90 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.19855766 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 2.19484382 |
| 92 | Glycosuria (HP:0003076) | 2.18973941 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 2.18973941 |
| 94 | Diastasis recti (HP:0001540) | 2.18879945 |
| 95 | Abnormality of the corticospinal tract (HP:0002492) | 2.18374282 |
| 96 | Abnormality of midbrain morphology (HP:0002418) | 2.15897589 |
| 97 | Molar tooth sign on MRI (HP:0002419) | 2.15897589 |
| 98 | Enlarged kidneys (HP:0000105) | 2.15589572 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.12980937 |
| 100 | Pendular nystagmus (HP:0012043) | 2.10700581 |
| 101 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.09709076 |
| 102 | Malnutrition (HP:0004395) | 2.08173200 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.07875112 |
| 104 | Cholecystitis (HP:0001082) | 2.07875112 |
| 105 | Hyperventilation (HP:0002883) | 2.06864571 |
| 106 | Abnormality of the intervertebral disk (HP:0005108) | 2.06617742 |
| 107 | Increased serum pyruvate (HP:0003542) | 2.06597769 |
| 108 | Abnormality of glycolysis (HP:0004366) | 2.06597769 |
| 109 | Nephronophthisis (HP:0000090) | 2.05778454 |
| 110 | Focal dystonia (HP:0004373) | 2.05219972 |
| 111 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.05190566 |
| 112 | Craniofacial dystonia (HP:0012179) | 2.04939738 |
| 113 | Irritability (HP:0000737) | 2.04202029 |
| 114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04120594 |
| 115 | Hypoglycemic seizures (HP:0002173) | 2.03798212 |
| 116 | Mitral stenosis (HP:0001718) | 2.03428508 |
| 117 | Abnormality of purine metabolism (HP:0004352) | 2.03107006 |
| 118 | Retinal dysplasia (HP:0007973) | 2.02636198 |
| 119 | Obsessive-compulsive behavior (HP:0000722) | 2.01037264 |
| 120 | Atonic seizures (HP:0010819) | 1.97686134 |
| 121 | Gingival bleeding (HP:0000225) | 1.96654672 |
| 122 | Polyphagia (HP:0002591) | 1.96579838 |
| 123 | Acute encephalopathy (HP:0006846) | 1.94694856 |
| 124 | Anxiety (HP:0000739) | 1.94414579 |
| 125 | Vaginal atresia (HP:0000148) | 1.94225263 |
| 126 | Hypothermia (HP:0002045) | 1.94177188 |
| 127 | Cholelithiasis (HP:0001081) | 1.93409982 |
| 128 | Medial flaring of the eyebrow (HP:0010747) | 1.93100068 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 1.91911514 |
| 130 | Congenital primary aphakia (HP:0007707) | 1.91059826 |
| 131 | Renal Fanconi syndrome (HP:0001994) | 1.90073194 |
| 132 | Myocardial infarction (HP:0001658) | 1.89581813 |
| 133 | Renal hypoplasia (HP:0000089) | 1.88969281 |
| 134 | Vomiting (HP:0002013) | 1.88223434 |
| 135 | Polymicrogyria (HP:0002126) | 1.87889996 |
| 136 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87020499 |
| 137 | Dicarboxylic aciduria (HP:0003215) | 1.87020499 |
| 138 | Hypsarrhythmia (HP:0002521) | 1.86997252 |
| 139 | Incomplete penetrance (HP:0003829) | 1.85947263 |
| 140 | Genital tract atresia (HP:0001827) | 1.85945422 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.85895553 |
| 142 | Ileus (HP:0002595) | 1.85398252 |
| 143 | Poikilocytosis (HP:0004447) | 1.84270039 |
| 144 | Aqueductal stenosis (HP:0002410) | 1.84034156 |
| 145 | Menorrhagia (HP:0000132) | 1.83521148 |
| 146 | Poor coordination (HP:0002370) | 1.83411370 |
| 147 | Pheochromocytoma (HP:0002666) | 1.83316892 |
| 148 | Systemic lupus erythematosus (HP:0002725) | 1.82947540 |
| 149 | Labial hypoplasia (HP:0000066) | 1.82494316 |
| 150 | EEG with generalized epileptiform discharges (HP:0011198) | 1.82213410 |
| 151 | Epileptiform EEG discharges (HP:0011182) | 1.81834806 |
| 152 | Sensorimotor neuropathy (HP:0007141) | 1.81233803 |
| 153 | Anencephaly (HP:0002323) | 1.80436560 |
| 154 | Opisthotonus (HP:0002179) | 1.80135087 |
| 155 | True hermaphroditism (HP:0010459) | 1.79072797 |
| 156 | Abnormality of the aortic arch (HP:0012303) | 1.78704632 |
| 157 | Midline defect of the nose (HP:0004122) | 1.78522702 |
| 158 | Neonatal onset (HP:0003623) | 1.78208522 |
| 159 | Delayed myelination (HP:0012448) | 1.78064764 |
| 160 | Cerebral hemorrhage (HP:0001342) | 1.77944173 |
| 161 | Dialeptic seizures (HP:0011146) | 1.77552259 |
| 162 | Brushfield spots (HP:0001088) | 1.76798447 |
| 163 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76139754 |
| 164 | Abnormality of the renal medulla (HP:0100957) | 1.75509524 |
| 165 | Pancreatic cysts (HP:0001737) | 1.75278696 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.74566598 |
| 167 | Specific learning disability (HP:0001328) | 1.74082949 |
| 168 | Pancreatitis (HP:0001733) | 1.73873653 |
| 169 | Down-sloping shoulders (HP:0200021) | 1.73647814 |
| 170 | Absence seizures (HP:0002121) | 1.73206316 |
| 171 | Absent eyebrow (HP:0002223) | 1.73161683 |
| 172 | Abnormality of placental membranes (HP:0011409) | 1.71368028 |
| 173 | Amniotic constriction ring (HP:0009775) | 1.71368028 |
| 174 | Spastic tetraplegia (HP:0002510) | 1.70955203 |
| 175 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.70853511 |
| 176 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.70853511 |
| 177 | Pancreatic fibrosis (HP:0100732) | 1.70713285 |
| 178 | Inappropriate behavior (HP:0000719) | 1.70003041 |
| 179 | Anophthalmia (HP:0000528) | 1.68104364 |
| 180 | Hemiparesis (HP:0001269) | 1.67889279 |
| 181 | Abnormality of salivation (HP:0100755) | 1.67774186 |
| 182 | Truncal obesity (HP:0001956) | 1.66249129 |
| 183 | Partial agenesis of the corpus callosum (HP:0001338) | 1.66037180 |
| 184 | Abnormal urine phosphate concentration (HP:0012599) | 1.65268959 |
| 185 | Hyperphosphaturia (HP:0003109) | 1.63925500 |
| 186 | Heterotopia (HP:0002282) | 1.63542437 |
| 187 | Urinary urgency (HP:0000012) | 1.62958463 |
| 188 | Focal motor seizures (HP:0011153) | 1.62546415 |
| 189 | Cystic liver disease (HP:0006706) | 1.62392224 |
| 190 | Meningocele (HP:0002435) | 1.62190887 |
| 191 | Patellar aplasia (HP:0006443) | 1.61692064 |
| 192 | Fetal akinesia sequence (HP:0001989) | 1.60833152 |
| 193 | Hypoplastic female external genitalia (HP:0012815) | 1.58727675 |
| 194 | Enlarged penis (HP:0000040) | 1.57509880 |
| 195 | Poor suck (HP:0002033) | 1.57332758 |
| 196 | Intellectual disability, moderate (HP:0002342) | 1.56828459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.49743036 |
| 2 | STK39 | 4.38492497 |
| 3 | SIK2 | 3.00879571 |
| 4 | OXSR1 | 2.87374336 |
| 5 | BCR | 2.53270776 |
| 6 | INSRR | 2.37404729 |
| 7 | CASK | 2.35516348 |
| 8 | ERBB4 | 2.30095902 |
| 9 | BCKDK | 2.04561127 |
| 10 | FGFR2 | 2.03751297 |
| 11 | MARK1 | 1.98539870 |
| 12 | DYRK3 | 1.97046496 |
| 13 | EPHB1 | 1.93561805 |
| 14 | WNK4 | 1.92100402 |
| 15 | UHMK1 | 1.90056564 |
| 16 | FGFR4 | 1.85046220 |
| 17 | CSNK1G3 | 1.75741531 |
| 18 | CSNK1A1L | 1.71801566 |
| 19 | MAPK13 | 1.65549957 |
| 20 | EPHA4 | 1.64051344 |
| 21 | FRK | 1.63031924 |
| 22 | CSNK1G1 | 1.60921540 |
| 23 | TAOK3 | 1.58886078 |
| 24 | PBK | 1.58487960 |
| 25 | PKN1 | 1.56201294 |
| 26 | MAP2K4 | 1.55431884 |
| 27 | SIK1 | 1.50697717 |
| 28 | AKT3 | 1.44025141 |
| 29 | ICK | 1.43942832 |
| 30 | CAMK1G | 1.41323686 |
| 31 | CSNK1G2 | 1.41119170 |
| 32 | MST1R | 1.40007574 |
| 33 | SGK2 | 1.39648878 |
| 34 | STK16 | 1.33157281 |
| 35 | MET | 1.31965661 |
| 36 | EPHB2 | 1.25991372 |
| 37 | CAMK1D | 1.22714332 |
| 38 | CAMK2B | 1.22119219 |
| 39 | DYRK2 | 1.20479596 |
| 40 | CDK19 | 1.15795620 |
| 41 | NTRK3 | 1.12379832 |
| 42 | MAP3K9 | 1.09987063 |
| 43 | PAK6 | 1.08907210 |
| 44 | PKN2 | 1.05659902 |
| 45 | NEK6 | 1.03247196 |
| 46 | PAK3 | 1.02941911 |
| 47 | BMPR1B | 1.01365099 |
| 48 | CAMK2G | 0.97155971 |
| 49 | IRAK2 | 0.93031581 |
| 50 | RPS6KA2 | 0.92208287 |
| 51 | MAPK4 | 0.89586138 |
| 52 | ABL2 | 0.85955225 |
| 53 | FGR | 0.85506466 |
| 54 | ERBB2 | 0.83755685 |
| 55 | PRKCQ | 0.83487064 |
| 56 | WNK1 | 0.83371460 |
| 57 | LMTK2 | 0.83325768 |
| 58 | CAMK2A | 0.81520795 |
| 59 | MAP2K7 | 0.79812884 |
| 60 | PIK3CG | 0.77754226 |
| 61 | GRK1 | 0.74192424 |
| 62 | EPHA2 | 0.73376909 |
| 63 | MAPK15 | 0.73322704 |
| 64 | PRKCZ | 0.69545149 |
| 65 | CAMK2D | 0.69238556 |
| 66 | NUAK1 | 0.68925530 |
| 67 | SGK3 | 0.67944910 |
| 68 | MAP3K4 | 0.67825761 |
| 69 | SGK494 | 0.63808263 |
| 70 | SGK223 | 0.63808263 |
| 71 | CSNK1E | 0.63405037 |
| 72 | MAP3K12 | 0.62777619 |
| 73 | PRKCG | 0.62739462 |
| 74 | EPHA3 | 0.62362557 |
| 75 | DYRK1B | 0.60377909 |
| 76 | PRKAA1 | 0.60235160 |
| 77 | PRKAA2 | 0.60226369 |
| 78 | DAPK2 | 0.58834022 |
| 79 | CDK5 | 0.58770566 |
| 80 | CAMKK1 | 0.58232582 |
| 81 | PNCK | 0.58038983 |
| 82 | NTRK1 | 0.56001607 |
| 83 | PRKCH | 0.55043166 |
| 84 | GSK3A | 0.53819470 |
| 85 | PASK | 0.53381544 |
| 86 | CAMK4 | 0.51777793 |
| 87 | MAP3K6 | 0.51054151 |
| 88 | PRKACG | 0.50331521 |
| 89 | PINK1 | 0.50102133 |
| 90 | NTRK2 | 0.49292209 |
| 91 | IRAK1 | 0.48913389 |
| 92 | PRPF4B | 0.48373364 |
| 93 | MAPK11 | 0.48213386 |
| 94 | LATS2 | 0.45866040 |
| 95 | PRKCE | 0.45166214 |
| 96 | MAP3K14 | 0.44155411 |
| 97 | STK11 | 0.43634132 |
| 98 | FLT3 | 0.43620971 |
| 99 | PRKG1 | 0.43355337 |
| 100 | CDK14 | 0.43212905 |
| 101 | BLK | 0.43153324 |
| 102 | MARK2 | 0.43075171 |
| 103 | WNK3 | 0.43057526 |
| 104 | GRK5 | 0.42904792 |
| 105 | MAP3K7 | 0.42722830 |
| 106 | MINK1 | 0.42470087 |
| 107 | ADRBK1 | 0.42330122 |
| 108 | PHKG2 | 0.41873310 |
| 109 | PHKG1 | 0.41873310 |
| 110 | PRKACA | 0.41850838 |
| 111 | ROCK2 | 0.40738963 |
| 112 | ERBB3 | 0.40094286 |
| 113 | NLK | 0.40076124 |
| 114 | FYN | 0.39834669 |
| 115 | ADRBK2 | 0.39185113 |
| 116 | MAP3K10 | 0.38445224 |
| 117 | DYRK1A | 0.38309403 |
| 118 | CDK15 | 0.37915816 |
| 119 | MKNK2 | 0.37046391 |
| 120 | CDK18 | 0.36641309 |
| 121 | PRKDC | 0.36133628 |
| 122 | CDK11A | 0.36020624 |
| 123 | SGK1 | 0.35142709 |
| 124 | PIK3CA | 0.34520974 |
| 125 | TLK1 | 0.34425706 |
| 126 | TYRO3 | 0.33866142 |
| 127 | ROCK1 | 0.33742881 |
| 128 | GSK3B | 0.33115210 |
| 129 | MAPK8 | 0.32775168 |
| 130 | FGFR1 | 0.31535870 |
| 131 | CAMK1 | 0.30494783 |
| 132 | CSNK1D | 0.29782801 |
| 133 | RPS6KA6 | 0.29125061 |
| 134 | NEK2 | 0.29115353 |
| 135 | RET | 0.28737075 |
| 136 | MAPK9 | 0.28234603 |
| 137 | CAMKK2 | 0.27967507 |
| 138 | KSR1 | 0.27402899 |
| 139 | MAPK14 | 0.27155315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26757299 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08446578 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.01856000 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97975025 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.80921889 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63240331 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62046354 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.59141716 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58196423 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.56348575 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44924226 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32012164 |
| 13 | Cocaine addiction_Homo sapiens_hsa05030 | 2.27901485 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27346296 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23771352 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22713222 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20068037 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.17774551 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.12793032 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10314666 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09298962 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.08842209 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98140996 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97074057 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94890536 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.91057052 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.82980831 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.82834059 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.82621771 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81409699 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75870482 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72522317 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72071741 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.71264761 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.70591223 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66335797 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.61106553 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60158010 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.59391443 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59310148 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57524806 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55594676 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.53141428 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52604663 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50466534 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.44362853 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.43663809 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43457049 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39634689 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39166330 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36260102 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31992306 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 1.31242705 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.27515650 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25528441 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.22990537 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20501343 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.19839639 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05594420 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04281007 |
| 61 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.03602637 |
| 62 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01260604 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00259261 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98236349 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96242193 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.95454838 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94732273 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.87510890 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.87434075 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85389774 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82676370 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80906662 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80642406 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80374728 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78081602 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77378996 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.76907630 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76670719 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75750551 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.70867101 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.70480304 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69784291 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69346482 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68161760 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65586629 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64987127 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64291117 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61033251 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60791814 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.60173349 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59126504 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58044779 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57485175 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56648416 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56625371 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56497603 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56445373 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56273905 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55663742 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55064159 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52839092 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50492813 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49230095 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48496927 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48399684 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48017804 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46975464 |
| 108 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46311163 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44496985 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42792025 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42677734 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42452224 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40339227 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40324967 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40160852 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40095051 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39103860 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37414195 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34097157 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32717968 |
| 121 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29763028 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.27123575 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23055518 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21945538 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.21549209 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18267194 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17110951 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12548581 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07475501 |
| 130 | Nicotine addiction_Homo sapiens_hsa05033 | 0.04497807 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.03447352 |
| 132 | Protein export_Homo sapiens_hsa03060 | 0.02720609 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.02250070 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00725334 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.00530778 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.1002512 |
| 137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0999177 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | -0.0913674 |
| 139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | -0.0883170 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0596141 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | -0.0583636 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0521691 |
| 143 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0482477 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0310220 |
| 145 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0276763 |
| 146 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0173064 |
| 147 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0162217 |
| 148 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0051186 |

